TTM
−$5.75
YoY change
+15.1%
5Y CAGR
—
Peak year (2009)
$9.30
Latest annual
−$6.41
EPS (Diluted) history chart for Insmed (INSM) from 1999 to 2025
Latest: −$6.41
EPS (Diluted) growth chart for Insmed (INSM) from 1999 to 2025
Latest: +15.1%
EPS (Diluted) history table for Insmed (INSM) from 1999 to 2025
| 2025 | −$6.41 | +15.1% | −$0.84 | ||
| 2024 | −$5.57 | +4.3% | −$0.23 | ||
| 2023 | −$5.34 | +36.6% | −$1.43 | ||
| 2022 | −$3.91 | +0.8% | −$0.03 | ||
| 2021 | −$3.88 | +28.9% | −$0.87 | ||
| 2020 | −$3.01 | 0.0% | $0.00 | ||
| 2019 | −$3.01 | -28.7% | +$1.21 | ||
| 2018 | −$4.22 | +46.0% | −$1.33 | ||
| 2017 | −$2.89 | +1.4% | −$0.04 | ||
| 2016 | −$2.85 | +41.1% | −$0.83 | ||
| 2015 | −$2.02 | +9.8% | −$0.18 | ||
| 2014 | −$1.84 | +15.0% | −$0.24 | ||
| 2013 | −$1.60 | +2.6% | −$0.04 | ||
| 2012 | −$1.56 | -39.1% | +$1.00 | ||
| 2011 | −$2.56 | +422.4% | −$2.07 | ||
| 2010 | −$0.49 | -105.3% | −$9.79 | ||
| 2009 | $9.30 | -826.6% | +$10.58 | ||
| 2008 | −$1.28 | -26.4% | +$0.46 | ||
| 2007 | −$1.74 | -70.5% | +$4.15 | ||
| 2006 | −$5.89 | -29.9% | +$2.51 | ||
| 2005 | −$8.40 | +20.9% | −$1.45 | ||
| 2004 | −$6.95 | +140.5% | −$4.06 | ||
| 2003 | −$2.89 | -73.8% | +$8.12 | ||
| 2002 | −$11.01 | -2.7% | +$0.30 | ||
| 2001 | −$11.31 | -74.1% | +$32.29 | ||
| 2000 | −$43.60 | +76.5% | −$18.90 | ||
| 1999 | −$24.70 | — | — |
- 2025−$6.41+15.1%
- 2024−$5.57+4.3%
- 2023−$5.34+36.6%
- 2022−$3.91+0.8%
- 2021−$3.88+28.9%
- 2020−$3.010.0%
- 2019−$3.01-28.7%
- 2018−$4.22+46.0%
- 2017−$2.89+1.4%
- 2016−$2.85+41.1%
- 2015−$2.02+9.8%
- 2014−$1.84+15.0%
- 2013−$1.60+2.6%
- 2012−$1.56-39.1%
- 2011−$2.56+422.4%
- 2010−$0.49-105.3%
- 2009$9.30-826.6%
- 2008−$1.28-26.4%
- 2007−$1.74-70.5%
- 2006−$5.89-29.9%
- 2005−$8.40+20.9%
- 2004−$6.95+140.5%
- 2003−$2.89-73.8%
- 2002−$11.01-2.7%
- 2001−$11.31-74.1%
- 2000−$43.60+76.5%
- 1999−$24.70—
EPS (Diluted) values are taken from Insmed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current diluted EPS (TTM) is −$5.75. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted EPS for Insmed (INSM) came in at −$6.41 – grew 15.1% year-over-year.
Between 2009 and 2025, Insmed diluted EPS plunged 168.9%, falling from $9.30 to −$6.41.
2009 marks the peak diluted EPS at $9.30, with the historical low of −$43.60 recorded in 2000.
Insmed EPS (Diluted) by Year
Insmed EPS (Diluted) 2025: −$6.41
2025's diluted EPS for Insmed came in at −$6.41, grew 15.1% from 2024.
Insmed EPS (Diluted) 2024: −$5.57
Insmed posted diluted EPS of −$5.57 in 2024, edged up 4.3% from 2023.
Insmed EPS (Diluted) 2023: −$5.34
In 2023, Insmed reported diluted EPS of −$5.34, surged 36.6% from 2022.
Insmed EPS (Diluted) 2022: −$3.91
Insmed diluted EPS in 2022 was −$3.91, edged up 0.8% from 2021.
Insmed EPS (Diluted) 2021: −$3.88
Insmed diluted EPS in 2021 was −$3.88.
See more financial history for Insmed (INSM). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Insmed (INSM), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation